Kite Pharma Inc (KITE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | KITE | KRYS | CYTK | ||
| Company | Kite Pharma Inc | Krystal Biotech Inc | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 179.99 | 360.45 | 80.80 | ||
| High | 179.99 | 376.28 | 84.54 | ||
| Low | 179.99 | 359.38 | 80.04 | ||
| Latest | 179.99 | 372.25 | 82.19 | ||
| Change | +0.20 | +12.32 | +1.39 | ||
| % Change | +0.11% | +3.42% | +1.72% | ||
| Volume | 100 | 1,307,800 | 7,164,200 | ||
| 20-Day Average Volume | 2,576,370 | 389,875 | 2,367,330 | ||
| Previous Close | 179.79 | 359.93 | 80.80 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 179.18 | 323.78 | 74.28 | ||
| 20-Day Raw Stochastic | 100.00% | 95.58% | 86.85% | ||
| 20-Day Relative Strength | 86.68 | 73.40 | 64.87 | ||
| Weighted Alpha | +211.40 | +173.64 | +92.69 | ||
| Today's Opinion | N/A | 100% Buy | 100% Buy | ||
| Previous Opinion | N/A | 100% Buy | 100% Buy | ||
| Last Month's Opinion | N/A | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.19% since 09/26/17 | +6.95% since 06/18/26 | +4.33% since 06/18/26 | ||
| Low | 179.55 on 10/02/17 | 337.60 on 06/23/26 | 78.27 on 06/23/26 | ||
| High | 179.99 on 10/03/17 | 376.28 on 06/26/26 | 84.54 on 06/26/26 | ||
| 1-Month | |||||
| %Chg | +1.09% since 09/01/17 | +22.98% since 05/26/26 | +7.73% since 05/26/26 | ||
| Low | 177.65 on 09/05/17 | 285.07 on 06/02/26 | 66.63 on 06/10/26 | ||
| High | 179.99 on 10/03/17 | 376.28 on 06/26/26 | 84.54 on 06/26/26 | ||
| 3-Month | |||||
| %Chg | +72.35% since 07/03/17 | +48.07% since 03/26/26 | +29.48% since 03/26/26 | ||
| Low | 100.09 on 07/10/17 | 242.00 on 03/31/26 | 58.65 on 04/29/26 | ||
| High | 179.99 on 10/03/17 | 376.28 on 06/26/26 | 84.54 on 06/26/26 | ||
| 6-Month | |||||
| %Chg | +130.11% since 04/03/17 | +47.62% since 12/26/25 | +30.23% since 12/26/25 | ||
| Low | 66.75 on 05/09/17 | 235.60 on 01/05/26 | 58.43 on 03/13/26 | ||
| High | 179.99 on 10/03/17 | 376.28 on 06/26/26 | 84.54 on 06/26/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,314,552 | 10,973,926 | 10,227,148 | ||
| Shares Outstanding, K | 57,370 | 29,480 | 124,433 | ||
| Annual Sales | 22,170,000 | 389,130,000 | 88,040,000 | ||
| Annual Net Income | -267,070,000 | 204,830,000 | -784,960,000 | ||
| Last Quarter Sales | 10,050,000 | 116,360,000 | 19,360,000 | ||
| Last Quarter Net Income | -109,820,000 | 55,930,000 | -206,030,000 | ||
| 60-Month Beta | 2.68 | 0.53 | 0.42 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.50 on 08/08/17 | 1.83 on 05/04/26 | -1.67 on 05/05/26 | ||
| Earnings Date | 11/08/17 | 08/03/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 48.12 | 0.00 | ||